The concept of drug repurposing, sometimes called repositioning, has become an increasingly attractive strategy in oncology ...
I had the opportunity to visit Zambia in Africa, so I have summarized my experience. This time, I will write about the ...
The federal government and the pharmaceutical company that developed mefloquine are trying to shut down a lawsuit launched in 2001 on behalf of veterans who believe the anti-malaria drug they were ...
Three years after graduating alongside his older brother at the Tshwane University of Technology (TUT), Oluwasegun Chijioke ...
Executive and Medical Director Dr. Remington Nevin Will Lead an Education Session October 3, from 1:00 to 4:00 p.m., at the Royal Canadian Legion's Montgomery Branch 351 PORT HURON, Mich., Oct. 2, ...
Scientists are racing to stamp out the disease in southeast Asia before unstoppable strains spread.
Mefloquine, aka Lariam, is now known to have a lengthy list of side effects such as paranoia, confusion, hallucinations and suicide, some of which can continue for years after taking it. The Canadian ...
Chez l'adulte et l'enfant de plus de 45 kg: la dose de méfloquine base recommandée en prophylaxie est de 250 mg en une prise par semaine. Chez l'adulte et l'enfant dont le poids est compris entre 15 ...
Cette rubrique recense les médicaments d’intérêt thérapeutique majeur (MITM) faisant actuellement l’objet de difficultés d’approvisionnement et pour lesquels il n’y a pas ou pas suffisamment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results